Ann: CEO Presentation to Bioshares Conference, page-21

David Blake's Bioshares used to have FTT as one of its choice biotech stocks. Then it abruptly dropped it after FTT reported the first recruiting stumble. Bioshares said something along the lines “dropping FTT as it looks like it going to take longer to recruit than it thought.”

I thought at the time that was rather harsh but it turned out to be a clever”seeing into the future” decision.

I don’t know if Bioshares has picked FTT up again as a choice stock, now it has solved the recruitment problem.

Does anyone know if it is back in the good stocks list?